Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025MedicineOpen Access

Oral Chinese patent medicine combined with transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: A Bayesian network meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

SJShan JiLYLing YinLFLili Feng

Discussion

Loading...

Member takes

Overview

Bayesian network meta-analysis reports oral chinese patent medicine enhances TACE outcomes in hepatocellular carcinoma, suggesting notable efficacy improvements.

Key Points

  • The combination of oral chinese patent medicine with TACE significantly improves treatment outcomes in hepatocellular carcinoma.
  • Objective response rate for TACE with oral chinese patent medicines was notably better than TACE alone, showing clear advantages.
  • Incorporating a Bayesian network meta-analysis, the research analyzed seventy-five trials with over 6900 participants to derive its findings.
  • Results highlight the potential of specific medications like Cidan, Jinlong, and Shenyi capsules in enhancing treatment effectiveness, although limitations exist.

Cite This Study

Ji et al. (2025) studied this question.

synapsesocial.com/papers/68c1955c9b7b07f3a061941bhttps://doi.org/10.1097/md.0000000000044332
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immune regulation and clinical response of Chinese herbal injections combined with TACE in hepatocellular carcinoma: a cumulative logit regression and Bayesian network meta-analysis2025 · 1 citations
  2. 2[Benefit-risk assessment of three oral Chinese patent medicines for activating blood and eliminating mass in treating primary liver cancer based on network Meta-analysis and multi-criteria decision analysis].2024
  3. 3Identifying the Well-suited Chinese Herbal Products for Hepatocellular Carcinoma (HCC) Patients in Terms of Hazard Ratio and Child-Pugh Score Improvement: A Frequentist Statistical Analysis Applying ‘Netmeta’2022
  4. 4Correction: Efficacy and safety of oral Chinese medicine combined with chemotherapy: a systematic review and network meta-analysis2025 · 1 citations
  5. 5Comparative efficacy of combination regimens based on interventional therapy and immune checkpoint inhibitors (ICIs) in patients with intermediate- and advanced-stage hepatocellular carcinoma: a systematic review, meta-analysis, and network meta-analysis2026 · 2 citations